RAPT
RAPT Therapeutics, Inc.
17.46
USD
This page is just a preview of the data found in TrendSpider’s full version
RAPT Therapeutics, Inc. stock is up 52.22% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 December’s closed higher than November. In the last 7 Unusual Options Trades, there were 1 PUT, 6 CALLs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 31 Oct 16:54 | 17 Nov, 2023 | 20.00 | 0 | ||
| 31 Oct 16:54 | 17 Nov, 2023 | 12.50 | 10 | ||
| 17 Nov 16:54 | 17 Nov, 2023 | 12.50 | 2128 | ||
| 17 Nov 17:19 | 17 Nov, 2023 | 12.50 | 2128 | ||
| 17 Nov 19:24 | 17 Nov, 2023 | 12.50 | 2128 | ||
| 17 Nov 19:32 | 17 Nov, 2023 | 12.50 | 2128 | ||
| 17 Nov 19:49 | 17 Nov, 2023 | 12.50 | 2128 |
RAPT Therapeutics, Inc. focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
